← Back to NASA Technology Projects
Completed TRL 6 (started at 4, targeting 6)
This project is currently (1) developing a novel, ultra-small footprint VF device for use during expeditionary spaceflight (FY18-19), and in FY19 proposes to (2) complete clinical validations to ensure performance is comparable to large-scale COTS VF devices and (3) complete initial operational testing. This device is intended to detect, monitor progression, and guide medical intervention of severe SANS cases during long-duration missions, as well as detect neuro-ocular pathology near the battlefield, aboard U.S. Navy ships, and during humanitarian missions. It will transition into space and terrestrial usage in FY20-21.
It's been discovered that all - or nearly all - long-duration crewmembers present with one or more signs of Spaceflight Associated Neuro-ocular Syndrome (SANS; formerly VIIP). No small-footprint devices exist to test the impact of SANS on crewmember visual performance during expeditionary spaceflight. Visual field (VF) testing is a well-established, non-invasive test used to assess the effect of neurological pathology on visual function.
Listed on TechPort itself — the most direct way to ask about this specific project.
This is early/mid-stage (TRL 6) — the most realistic path in is NASA SBIR/STTR, which funds small businesses and research institutions to develop technology aligned with NASA's needs (equity-free, phased funding). Check whether a current SBIR/STTR solicitation topic overlaps with this project's technology area, or contact the project directly (above) to ask.
None of these are guaranteed paths for this specific project — TechPort itself doesn't have an "apply" button. Reaching out to the contact(s) above with a specific question is usually the fastest way to find out what's actually open.